Sigma class GST (Prostaglandin D synthase), FhGST-S1, is present in the excretory-secretory products (ES) of the liver fluke parasite Fasciola hepatica as cargo of extracellular vesicles (EVs) released by the parasite. FhGST-S1 has a well characterised role in the modulation of the immune response; a key fluke intercession that allows for establishment and development within their hosts. We have resolved the three-dimensional structure of FhGST-S1 in complex with its co-factor glutathione, in complex with a glutathione-cysteine adduct, and in a glutathione disulfide complex in order to initiate a research pipeline to mechanistically understand how FhGST-S1 functions within the host environment and to rationally design selective inhibitors. The overall fold of FhGST-S1 shows high structural similarity to other Sigma class GSTs. However, a unique interdomain disulfide bond was found in the FhGST-S1 which could stabilise the structure within the host gastro-intestinal environment. The position of the two domains of the protein with respect to each other is seen to be crucial in the formation of the active site cleft of the enzyme. The interdomain disulfide bond raises the possibility of oxidative regulation of the active site of this GST protein.
SCIEnTIfIC REPORTS | (2019) 9:902 | DOI:10.1038/s41598-018-37531-5 glutathione (GSH) to a wide range of hydrophobic exogenous and endogenous toxic compounds resulting in their inactivation and an increase in their water solubility for ease of excretion and further metabolism 8 . The GSTs also have predicted roles in sequestration of toxins as part of Phase III drug metabolism 8 . In adult helminth parasites, GSTs are potentially the major detoxification system, with limited Phase I cytochrome P450 activities and limited other Phase II activities 8,9 . GSTs were presumed to be only detoxification proteins, however house-keeping activities in metabolism have been identified. For example, Sigma GSTs have been found to have prostaglandin synthase activity and other GSTs have been shown to be involved in the binding of a number of hydrophobic substrate compounds for transport 9 . Structures of GST family enzymes have revealed a conserved canonical GST fold with two domains. The smaller N-terminal domain consists of a thioredoxin like fold, whilst the larger C-terminal domain is entirely α-helical 7 .
Parasitic helminths may have adapted the house-keeping role of Sigma GSTs in synthesising prostaglandins to help modulate the immune response of their hosts. In F. hepatica a new Sigma class GST (FhGST-S1) was identified by proteomic analysis 10 and confirmed to be an excretory-secretory protein 11 that can be transported from the parasite via extracellular vesicles 12 . Purified FhGST-S1 was confirmed to possess prostaglandin synthase (PGDS) activity and the enzyme activated host immune cells (dendritic cells and macrophages) to produce prostaglandins and elevated levels of Th2 cytokines. Thus, extracellular FhGST-S1 manipulations of host cell phenotypes may support F. hepatica to drive the Th2 response and establish its long-term infections 11, 13 . Furthermore, FhGST-S1 when trialled as a vaccine reduced pathology normally associated with liver fluke infection 14 .
Structural information is a prerequisite for mechanistically understanding biochemical activity and for the rational design of inhibitor compounds. Here we present the 1.6 Å three-dimensional structures of the FhGST-S1 in the presence of GSH alone (holo-structure), cysteine covalently attached to the GSH (CGL complex), and of a glutathione disulfide (GSSG-structure).
Results and Discussion
Structural studies. Both the FhGST-S1 holoenzyme and the GSSG complex were crystallised in the same orthorhombic space group with slightly different unit cells ( Table 1) . As the crystallisation media contained potassium bromide several bromide binding sites with partial occupancy were located in both structures. Several DMSO molecules were located in the GSSG complex structure, where this organic solvent was added to increase the solubility of the inhibitor TCBZ. The electron density obtained from the structural results has allowed the positioning of 209-210 amino acid residues out of the 211 in each monomer in both structures. The 
Holoenzyme GSSG complex
is the intensity of the reflections h, ∑ h is the sum over all t h e reflections and ∑ J is the sum over J measurements of the reflections. R cryst = ∑||Fo|−|Fc||/∑|Fo|. Wilson B-factor was estimated by SFCHECK 36 . The Ramachandran plot analysis and G-factor calculation were performed by PROCHECK 15 .
SCIEnTIfIC REPORTS | (2019) 9:902 | DOI:10.1038/s41598-018-37531-5 electron density was of high enough quality to differentiate several main chain second positions and multiple alternative side chain positions in both structures. The disulfides in both structures were partially formed and the cysteines were refined both as disulfide and free thiols. In both structures Pro54 of each subunit is in the cis conformation. Both models have acceptable stereochemical parameters for their observed resolution as judged by PROCHECK 15 . Of the non-glycine residues in the protein 92% fall into the most favoured regions of the Ramachandran plot for both the holo and GSSG complex structures.
Monomer structure. The FhGST-S1 monomer adopts the canonical GST fold with two domains, the smaller N-terminal domain with a thioredoxin-like fold (residues 2-83) and the larger all α-helix C-terminal domain (residues 84-211) ( Fig. 1 ). The N-terminal domain is formed by a 4 stranded mixed β-sheet with Richardson topology −1 × 2 1 16 . The sheet is flanked by helices α1 (residues 15-26) and α3 (residues 71-81) on one side and on the other by α2 (residues 41-51) including the short 3 10 helices α2 and α2′. The N-terminal domain has the folding pattern βαβαββα. Residue Pro54 at the loop between helix α2′ and strand β3 is in the cis conformation. Conservation of a cis residue at this position has been reported for all GST structures 17 . A β-bulge is present after strand β3 (residue Gly 60). The all α-helical C-terminal domain contains 6 helices. The N-and C-terminal domains interact through packing of helices α1 and α3 against helices α6 and α4 with interactions of helix α9 with helix α1. Each monomer contains an intermolecular disulfide bond between cysteine residues C26 and C196 at partial occupancy ( Fig. 2 ). This results in a bond between the N-terminal domain helix α1 and the C-terminal domain helix α9. This is the first time that such an interdomain disulfide bond has been observed in a GST. The active site is located in the cleft between the two domains of the monomer and as such would be altered by movement between the two domains. The presence of the interdomain disulfide bond raises the possibility of oxidative regulation of the active site of this GST protein.
Quaternary Structure. The FhGST-S1 forms dimers related by a molecular dyad with approximate dimensions 46 Å × 53 Å × 50 Å. The formation of the dimer buries 2922 Å 2 of the solvent accessible surface area. This means that 13% of the subunit solvent accessible surface of 11189 Å 2 is buried upon oligomerization. Interaction between the two subunits is by 11 hydrogen bonds and 151 non-bonded contacts between 21 amino acid residues from each chain. Like other sigma class GSTs, FhGST-S1 lacks the hydrophobic "lock and key" motif found in Alpha, Mu and Pi class GSTs 18 .
Active Site. Clear density was observed for the glutathione in each monomer of each structure and was modelled as such. Additional density was observed in subunit A of the holo-structure, continuous from the Sγ of the glutathione moiety and extending to the Tyr106 OH. The additional density has been successfully modelled with cysteine covalently attached to the glutathione by a disulfide bond (cystine glutathione, CGL; Fig. 3 ). Additional density was also observed in each subunit of the GSSG-structure, continuous from the Sγ of the glutathione. In both subunits this extra density has been successfully modelled as a further glutathione molecule ( Fig. 4 ) at partial (0.7) occupancy, therefore resulting in a mixture of GSH and glutathione disulfide present in the active site ( Fig. 5 ).
Figure 1.
A cartoon presentation of the monomer fold of FhGST-S1.
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The G-Site. Subunit The G-site is located on the interface of two FhGST-S1 GST monomers, which are shown as a cartoon representation in colours green and cyan respectively. The CGL complex, which contains GSH forming a disulfide bond with a free cysteine residue, is shown bound to the G-site. The CGL molecule and the two active site tyrosine residues, 10 and 106 are presented as stick models. The residue Phe13 has a significant side chain movement (Fig. 6 ). Phe13 in subunit A has moved closer to the active site with a distance between the two Cβ positions of 0.9 Å. The side chain has rotated about Cβ by 70°. This residue is involved in non-bonded contacts to the cysteine ligand. Superposition of the holo-structure and the GSSG-structure (RMSD 0.28) reveals that the Phe13 residue occupies the same position as that found in the holo structure ( Fig. 6 ). There are few changes between the structures, except around the position of the disulfide bond, where there are local changes to the disulfide bond position and the position of the surrounding Cα-backbone.
Structural comparisons. The FhGST-S1 structure was submitted to DALI 19 for comparison to other known structures. The top hit, (with a Z-score of 29.7, RMSD 1.5 Å) is the structure of the Sigma class GST from Schistosoma haematobium (pdb 2C80; Sh28GST). The studies of the S. haematobium enzyme revealed that the active site tyrosine residue adopted two side chain positions termed 'in' and 'out' depending on whether they pointed in towards the GSH thiol group or not 20 . The studies of these authors examined the data of a number of other GST structures and found that these structures also contained additional density and space for the 'out' position of the Tyr residue. In the structures reported here, there is no additional density for the alternative 'out' position of Tyr10 and in fact, very little movement is observed between the two monomers. The authors of these studies found Arg35 was highly conserved and was found in 68% of Alpha 21 . In FhGST-S1, whilst Asp33 is conserved, Arg35 is not and is found to be a glutamine (Gln35), therefore not conserving this interaction. The structure of an extracellular Sigma class GST from the human filarial nematode parasite Onchocerca volvulus (OvGST1 -pdb 2HNL) has previously been reported 22 . FhGST-S1 superposes to the OvGST1 with an RMSD of 1.95 Å across 192 residues. The OvGST1 has also been shown to exhibit PGDS activity and is thus implicated in immune response modulation 22 . Interestingly, the nematode enzyme shows a higher sequence identity to mammalian PGDS than to other parasitic worm Sigma class GSTs 22 . Although OvGST1 is a Sigma class GST, the structure revealed it to have two 'lock and key' interactions at the dimer interface, one of which is akin to that found in human haematopoietic PGDS 22, 23 . This feature is not observed in the F. hepatica GST-S1. However, the prostaglandin binding site of the OvGST1 was found to differ considerably to those of mammalian PGDS proteins 22 , suggesting a different mode of binding is required for the filarial enzyme. PGDSs have a conserved Trp residue in the loop between α4 and α5, causing a backbone kink, resulting in the shortening of helix α4. Like the OvGST1, FhGST-S1 does not have this Trp residue and therefore has a longer α4, although the FhGST-S1 helix aligns better to that of the mammalian PGDSs (Fig. 7) . Again like the OvGST1, FhGST-S1 has little conservation of the proposed prostaglandin binding residues, suggesting as with the OvGST1, a different mode of prostaglandin binding. Of the residues proposed to be involved in prostaglandin binding in OvGST1 22 , only three are the same amino acid in the equivalent positions in FhGST-S1. As such, it is difficult to currently ascertain if the FhGST-S1 is acting in the same way as the OvGST1. The highest sequence identity human GST counterpart is a PGDS (pdb 3EE2). FhGST-S1 superposes to this enzyme with an RMSD of 1.91 Å over 192 Cα atoms. Interestingly, with respect to selectivity and potential drug development, FhGST-S1 demonstrated a different inhibition profile to hGSTS1-1 (PGDS) when probed with a series of isoquinolyl inhibitors that were synthesised as previously described 24 ( Supplementary Table 1 ).
Conclusions.
The Fasciola Sigma class GST, FhGST-S1 has been shown to have the same fold as other GSTs and to be highly similar to other Sigma class GSTs. However, the protein was shown to have an interdomain disulfide bond, which has not been observed in any GST structures previously described. The relationship of the two domains with respect to each other is crucial in the formation of the active site cleft and therefore the presence of a disulfide bond to stabilise this interaction is of great interest. The enzyme is found in fluke extracellular vesicles and this indicates that it does not require a classical leader sequence to leave parasite tissues. If the Sigma GST FhGST-S1 is then pro-actively released into the host gastro-intestinal environment via EVs then the presence of the disulfide bond would stabilise the released protein in its non-reducing host environment. Figure 7 . Superposition of helix α4 of FhGST-S1 (green), O. volvulus GST-1 (pink, pdb 2HNL), and PGDS from Rattus norvegicus (yellow, pdb 1pd2), and Homo sapiens (blue, pdb 1IYI; orange, pdb 3EE2). The FhGST-S1 helix is not as long as that from O. volvulus GST, and aligns better to the equivalent mammalian helix.
Materials and Methods
Expression and purification. The FhGST-S1 was cloned into pET23a (Novagen) as described previously 11 .
The recombinant protein was expressed in E. coli BL21 (DE3) cells (Novagen). Initial cultures were grown overnight at 37 °C in LB supplemented with 100 μg/ml ampicillin. The Initial culture was used to inoculate a 1 L culture (LB, 100 μg/ml ampicillin) diluted down to an OD 600 of 0.05-0.1. This culture was grown for a further 5 hours at 37 °C shaking at 200 rpm. The culture was transferred to 28 °C and allowed to equilibrate for 30 minutes before the addition of IPTG to a final concentration of 0.5 mM. The culture remained at 28 °C for a further 2 hours before cells were harvested by centrifugation (8000 × g, 20 minutes, 4 °C). Cell pellets were resuspended in 50 mM Tris-HCl, pH 8.0 and cells disrupted by sonication (SoniPrep Ultrasonic Disintegrator, Sanyo) with incubations on ice between sonication bursts. Cell debris was removed by centrifugation (12000 × g, 20 minutes, 4 °C). The clarified extract was applied to a pre-swollen glutathione agarose column (Sigma-Aldrich) equilibrated with 20 mM potassium phosphate pH 7.0. The glutathione agarose column was washed with equilibration buffer and eluted using 5 mM glutathione in 50 mM Tris pH 8.0. Elution fractions containing FhGST-S1 were pooled and concentrated using a centrifugal concentrator (PES membrane, 10 kDa MWCO, Sartorius) and applied to a pre-equilibrated Superdex 200 column (G.E. Healthcare) and eluted with 100 mM Tris-HCl, pH 7.5. The recombinant FhGST-S1 enzyme was shown to be active, following the conjugation of substrates 1-chloro-2,4-dinitrobenzene (CDNB) and reduced glutathione according to an adaptation of the method described previously 25 .
Crystallisation and data collection. Purified FhGST-S1 was concentrated to 10 mg/ml using a centrifugal concentrator (PES membrane, 10 kDa MWCO, Sartorius) at 4 °C and frozen in aliquots. 10 μl of 100 mM glutathione and 10 μl 100 mM TCBZ in DMSO was added to 380 μl of protein. The sample was centrifuged for 5 minutes to clarify the solution. Crystallisation screening was carried out using an Oryx 6 crystallisation robot (Douglas Instruments) in microbatch mode. The crystals were grown from condition G10 of JCSG-plus 26 , Molecular Dimensions Ltd), 0.15 M KBr, 20% (w/v) PEG 3350. Multiple crystals grew in clusters and these were cut whilst in the droplet to obtain a single crystal. For flash freezing the crystal was harvested into a cryogenic liquor containing 100 mM Tris-HCl pH 7.5, 0.15 M KBr, 17% (w/v) PEG 3350, 25% (w/v) PEG 400. Data were collected in house at 100° K on a MAR Research 345 Image Plate mounted on a Siemens rotating anode generator using copper Kα radiation and XENOCS FOX2D CU_25P mirrors. An initial data set was collected to 2.0 Å resolution, and the background diffraction from other contaminating crystal lattices was found to be minimal and did not interfere with the data processing. A further data set was collected to 1.6 Å from the same crystal and was used for the structure solution. Structure solution of this data set revealed a cysteine ligand bound in the active site. Further crystals were grown from protein concentrated to 20 mg/ml with the addition of 0.5 μl of 100 mM glutathione and 4 μl 1 M TCBZ in DMSO added to 40 μl of protein. The sample was centrifuged to clarify the solution as before. Crystals were harvested into the cryogenic mother liquor described above, with the inclusion of 100 mM TCBZ in DMSO. Again the diffraction data revealed the crystals to contain more than one lattice, but this was not detrimental to data processing. Data were collected in house to 1.6 Å resolution. Solution of this data revealed the presence of glutathione disulfide GSSG molecule bound in the active site. Structure solution, model building and refinement. Data were processed with MOSFLM 27 and SCALA 28 using the CCP4 program suite 29 . The FhGST-S1 structure was solved by molecular replacement using the program MOLREP 30 with the S. mansoni 28 kDa GST structure (1U3I) as the model. Refinement was carried out using REFMAC 5.2 31 and model building was carried out using COOT 32 . Water molecules were added using ARP/wARP 33 . Images were created using the molecular graphics program PyMol 34 .
